EUCTR2007-002061-12-DE进行中（未招募）不适用
A randomized phase III studyComparing biweekly and tailored epirubicin + cyclophosphamide followed by biweekly tailored docetaxel (dtEC -- dtT)(A-arm) versus three weekly epirubicin + cyclophosphamide, 5-fluorouracil followed by docetaxel (FEC -- T)(B-arm) in lymph node positive or high risk lymph node negative breast cancer patients- a continuation of the feasibility part of the SBG 2004-1 study - PANTHER
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- SBG
- 入组人数
- 2,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •1: Histological proven invasive primary breast cancer, with at least 5 (recommended 10) removed axillary lymph nodes. Interval between definitive surgery that includes axillary lymph node dissection and registration must be less than 60 days. Paraffin block from the primary tumour must be retained (not mandatory for Austrian sites).
- •Frozen tumour tissue is strongly recommended to be stored.
- •2. Receptor negative or positive tumours with 1 or more positive axillary lymph nodes (more than 0.2 mm) OR axillary node negative breast cancers if the primary tumour is larger than 20 mm and receptor negative (Er and Pgr with no receptor content) and being Elston grade III.
- •3. A primary breast cancer patient being 35 years or younger considered suitable for adjuvant chemotherapy (may be receptor negative or positive, HER-2/neu negative or positive, with or without axillary lymph node metastases).
- •4. Macroscopically and microscopically free margins after radical surgery (no cancer cells at borders of resection).
- •5. No proven distant metastases (negative chest/pulmonary X-ray, bone scintigram (when clinical signs of skeletal metastases or elevated ALP) supplemented with normal conventional X-ray of hot spots, normal liver function test and haematological function tests; when abnormal values, CT or ultrasound of the liver, patient can be included if no metastases are demonstrated.
- •6. Female age 18-65.
- •7. Ambulant patients (ECOG 1 or less).
- •8. No major cardiovascular morbidity NYHA I or II. (Appendix 3).
- •9. Written informed consent according to the local ethics committee requirements.
- •10. Patients of childbearing potential should have a negative pregnancy test within seven days of registration. (In Austria, pregnancy tests have to be repeated monthly during the treatment phase).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1: Previous neo-adjuvant treatment.
- •2: Non-radical surgery (histopathological positive margins).
- •3: Proven distant metastases.
- •4: Pregnancy or lactation.
- •5: Other serious medical condition.
- •6: Previous or concurrent malignancies at other sites, except basal cell carcinoma and/or squamous cell carcinoma in situ of the skin or cervix. Patients with previous breast cancer (invasive and/or ductal carcinoma in situ) in the other breast without loco-regional (large lung volumes) radiotherapy, without objective findings for relapse, with > 5 years since diagnosis can be included.
- •7: Abnormal laboratory values precluding the possibility to safely deliver the used cytotoxic agents in the study.
- •8: Hypersensitivity to drugs formulated in polysorbate 80.
- •9: Peripheral neuropathy grade =2.
研究者
相似试验
招募中
3 期
PRABITAS studycolorectal cancerJPRN-jRCTs041230120Taniguchi Hiroya890
进行中（未招募）
1 期
Randomised Phase II study of biweekly versus fractionated triweekly combination Taxotere-Cisplatin-5FU in advanced gastric and gastro-esophageal junction cancer - DoGE01EUCTR2008-000551-10-BEInstitut Jules Bordet134
招募中
不适用
Randomized Phase III Clinical Trial of Weekly versus Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical CancerNeoplasmsKCT0003214Korea Cancer Center Hospital374
已完成
2 期
Weekly versus three-weekly docetaxel in women with breast cancerCancerISRCTN09184069nited Lincolnshire Hospitals NHS Trust (UK)82
进行中（未招募）
3 期
JCOG2014: Randomized phase III study of bi-weekly trifluridine/tipiracil plus bevacizumab vs trifluridine/tipiracil alone for chemorefractory metastatic colorectal cancerColorectal cancerJPRN-jRCTs031210544YAMAZAKI Kentaro420